Global Diagnostics PCR Market Growth 2025-2031

Global Diagnostics PCR Market Growth 2025-2031

The global Diagnostics PCR market size is predicted to grow from US$ 549 million in 2025 to US$ 628 million in 2031; it is expected to grow at a CAGR of 2.3% from 2025 to 2031.

PCR is the Gold Standard in Diagnostic Testing. Polymerase chain reaction (PCR) is able to copy and multiply specific target DNA molecules has opened the door to diagnosing diseases across multiple areas quickly, accurately, and as time progresses at lower cost. Polymerase chain reaction (PCR) is a quick, easy way to create unlimited copies of DNA from just one original strand. These millions of copies of a section of DNA are made in just a few hours with the goal to recreate enough DNA for multiple testing uses, such as sequencing or infection identification.

Global Diagnostics PCR key players include Thermo Fisher Scientific, Bio-rad, Roche, Qiagen, Bioer, etc. Global top five manufacturers hold a share over 75%. North America is the largest market, with a share over 40%, followed by Europe and China, total have a share over 40 percent. In terms of product, Real-Time PCR is the largest segment, with a share about 55%. And in terms of application, the largest application is Hospital, followed by Independent Laboratories.

LP Information, Inc. (LPI) ' newest research report, the “Diagnostics PCR Industry Forecast” looks at past sales and reviews total world Diagnostics PCR sales in 2024, providing a comprehensive analysis by region and market sector of projected Diagnostics PCR sales for 2025 through 2031. With Diagnostics PCR sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostics PCR industry.

This Insight Report provides a comprehensive analysis of the global Diagnostics PCR landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostics PCR portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diagnostics PCR market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostics PCR and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostics PCR.

This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostics PCR market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Real-Time PCR
Digital PCR
Other

Segmentation by Application:
Hospital
Independent Laboratories
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Roche
Bio-rad
Qiagen
Agilent
Bioer
Analytik Jena
Techne
Biosynex

Key Questions Addressed in this Report

What is the 10-year outlook for the global Diagnostics PCR market?

What factors are driving Diagnostics PCR market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Diagnostics PCR market opportunities vary by end market size?

How does Diagnostics PCR break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.